Communicating value to US Payers: Insights for Pharma and Medtech
March 18, 2025 | Market Access, US, value
What do global market access teams need to know about the US market? What do US payers expect to hear from Pharma and Medtech companies? What kind of value messaging resonates in the US? How do you prepare for launch in a market as diverse as the US? In this live Global Whispers webinar, Louise Maddison (Senior Consultant – Global Market Access, Mtech Access – Powered by Petauri) will interview some of our colleagues from Petauri Advisors who are either former payers, or former industry market access leads in the US.
Join Louise on Wednesday 26th March at 4.00pm (GMT)/5.00pm (CET)/9.00am (PDT)/12.00pm (EDT) as she puts your questions to:
- Rory Davies – Vice President of Value and Access, Petauri Advisors, with extensive past experience in Chief Clinical roles at Cigna, Flipt and WellDyne
- Dan Vanderpoel – Executive Vice President, Strategic Payer Marketing; Head, Client Solutions, Petauri and former Manager, Trade Relations at Humana
- Shana Gunderson Hua – Vice President of Value and Access, Petauri Advisors and former Medical Affairs Executive Director at Genentech and former AVP of Pharmaceutical Strategy and Contracting at Cigna and Express Scripts (now Evernorth)
In this Global Whispers webinar, we will explore what global market access teams need to know about market access and payer engagement in the US. We will explore how and why value messaging, pricing, and launch strategies are developed differently for the US market, compared to other key launch markets, and what this means for global teams preparing for US launch or taking a US-developed proposition internationally.
To do this, we are delighted to welcome guest speakers from the Petauri Advisors and ACE team; an in-house team of former US access decision makers, with experience across all areas of US healthcare, including Medicare, Medicaid, and Commercial.
Rory, Dan, and Shana will together enable us to gain a broad, yet deep, view of the US market, from both the payer and industry perspective.
We will explore:
- What you need to know about the nuances of launching in the US market
- What US payers need to hear about your product
- How to craft value messaging that resonates with the US market
- Key differences between the US and other global markets with regard to access, customer engagement, and pricing strategies
- What these differences mean for global and local teams
- Opportunities and challenges when launching new medicines/medical devices/diagnostics in the US
If you cannot attend the webinar but would like to know more, please register nonetheless, as all registrants will receive a recording of the webinar.
The webinar is free and open to all market access, HEOR, strategic, and commercial teams in Pharmaceutical, Medtech, and Diagnostics companies. We also welcome attendees from healthcare systems. Some colleagues from other organisations may attend at the discretion of Mtech Access and Petauri.
This content was provided by Petauri Evidence